AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer

NCT01233687 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: AMG 102 and erlotinib

Sponsor

Ahmad Tarhini

Collaborators

[object Object]